Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1123430

	registered interest
	date	26/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential role of dentists and oral health professionals in supporting the diagnosis of diabetes.
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	uin	247979
	answer	answer is ministerial correction date of answer 07/05/2019 answer text <p>The Department has no knowledge of any assessment or planned assessment into the potential role of dentists and oral health professionals in supporting the diagnosis of diabetes.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/05/2019 16:40:11 answering member 4455 label Biography information for Seema Kennedy
	tabling member	338 label Biography information for Keith Vaz

1110551

	registered interest
	date	09/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps is the Government taking to ensure timely access to maintenance medication for people with cancer.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	242692
	answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The Department fully understands that maintaining access to cancer medication is vitally important to many people in this country.</p><p> </p><p>There is already a team within the Department that deals with medicine supply issues arising both in the community and hospitals. We have well established procedures to deal with medicine shortages, from whatever cause, and work closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England and others operating in the supply chain to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p> </p><p>If we are aware of issues with cancer medications we work with national clinical experts to advise on management plans and ensure that appropriate information is provided to the National Health Service and specialist patient groups.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:58:08 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

1110552

	registered interest
	date	09/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the appraisal process for personalised treatments for small patient groups.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	242693
	answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care. Through its technology appraisal and highly specialised technologies programmes, NICE plays an important role in ensuring that patients are able to benefit from effective new treatments, including treatments for small numbers of patients. NICE has recommended a number of drugs for small patient populations through these programmes that are now routinely funded by the National Health Service for eligible patients.</p><p> </p><p>NICE periodically reviews its methods and processes to ensure that they keep pace with developments in science and healthcare. NICE will be carrying out a review of its technology appraisal and highly specialised technologies methods in 2019/20.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:55:57 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

1121970

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 April 2019 to Question 242692 on Cancer: Drugs, what steps the Government is taking to give timely NICE and NHS approval to enable access to maintenance medication for people with cancer.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	245610
	answer	answer is ministerial correction date of answer 25/04/2019 answer text <p>Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources. NHS England is legally required to fund cancer drugs recommended in NICE technology appraisal guidance.</p><p>The Government wants patients with cancer to be able to benefit from rapid access to effective new drugs, including for maintenance treatment. Under arrangements introduced in 2016, NICE now develops technology appraisal guidance for the NHS on all new cancer drugs. Wherever possible, NICE aims to issue draft guidance on new cancer drugs before licensing and to publish final guidance within 90 days of licensing.</p><p>Funding is available through the Cancer Drugs Fund from the point at which NICE draft recommendations are published, or if the drug is not currently licensed, from the point of licensing. This ensures patients are able to benefit from effective new cancer drugs as quickly as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/04/2019 14:05:35 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

1110572

	registered interest
	date	09/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bowel Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timescale is for the introduction of the faecal immunochemical test for the bowel cancer screening programme in England.
	tabling member constituency	Nottingham North
	tabling member printed	Alex Norris
	uin	242932
	answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The UK National Screening Committee advised that Faecal Immunochemical Test (FIT) is a more sensitive and accurate test than guaiac faecal occult blood test (FOBt), and that more bowel cancers could be detected, and recommended that FIT should replace the currently used FOB test.</p><p> </p><p>Full replacement of the current FOBt with FIT across all Hubs in the NHS Bowel Cancer Screening Programme is planned for summer 2019.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:59:51 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4641 label Biography information for Alex Norris

1123090

	registered interest
	date	25/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome: Greater London
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will allocate additional funding to support charities providing direct services to people with ME in London.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	247626
	answer	answer is ministerial correction date of answer 03/05/2019 answer text <p>Services for people with myalgic encephalomyelitis; including those provided by the voluntary sector, are commissioned by local clinical commissioning groups. It is the responsibility of the local National Health Service commissioners to ensure NHS services are commissioned to meet local need and that they address any shortfalls in provision.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 03/05/2019 13:01:02 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1447 label Biography information for Andrew Rosindell

1123095

	registered interest
	date	25/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the Government has made an assessment of the potential merits of changing the maximum nicotine content of 20 mg/ml currently allowed in vaping products in the event that the UK leaves the EU Tobacco Products Directive.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	247628
	answer	answer is ministerial correction date of answer 03/05/2019 answer text <p>No assessment has currently been made.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 03/05/2019 13:21:13 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1447 label Biography information for Andrew Rosindell

1123111

	registered interest
	date	25/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Vaccination: Disinformation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle misinformation in anti-vaccine literature.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	247635
	answer	answer is ministerial correction date of answer 03/05/2019 answer text <p>I refer the hon. Member to the answer the Parliamentary Under Secretary of State for Mental Health, Inequalities and Suicide Prevention (Jackie Doyle-Price MP) gave on 26 March 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-03-18/233488/" target="_blank">233488</a>.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 03/05/2019 13:11:25 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1447 label Biography information for Andrew Rosindell

1121932

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress is being made on the development of the UK CAR-T Cell Therapy Strategy; when stakeholders will be invited to participate in the development of that strategy; and when he plans to publish that strategy.
	tabling member constituency	Newton Abbot
	tabling member printed	Anne Marie Morris
	uin	245799
	answer	answer is ministerial correction date of answer 25/04/2019 answer text <p>The National Health Service in England is one of the first health services in the world to deliver Chimeric Antigen Receptor T Cell (CAR-T) Therapy. The first patient began their treatment in October 2018 for B cell acute lymphoblastic leukaemia. NHS England continues to focus on supporting implementation of these CAR-T products in the first wave of treatment centres, and are preparing for a potential second wave of treatment centres to begin delivering the treatment later in 2019. There are no plans to develop or publish a strategy.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/04/2019 14:04:42 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4249 label Biography information for Anne Marie Morris

1109022

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sterilisation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many Clinical Commissioning Groups commission vasectomy services for patients who are not in exceptional circumstances.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	240100
	answer	answer is ministerial correction date of answer 08/04/2019 answer text <p>This is a matter for local clinical commissioning groups, and the information requested is not held centrally by the Department or NHS England.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/04/2019 15:26:41 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4657 label Biography information for Anneliese Dodds